Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ann Thor

Concepts (453)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
72
2023
2234
4.270
 Why?
Receptor, ErbB-2
28
2020
340
3.070
 Why?
Metformin
10
2018
330
2.100
 Why?
Neoplasms, Germ Cell and Embryonal
7
2024
77
1.880
 Why?
Testicular Neoplasms
7
2024
110
1.850
 Why?
Tamoxifen
11
2023
202
1.690
 Why?
Receptors, Estrogen
17
2020
436
1.540
 Why?
Thyroid Hormones
2
2023
61
1.490
 Why?
Biomarkers, Tumor
17
2024
1272
1.300
 Why?
Receptor, ErbB-3
8
2016
44
1.300
 Why?
Lymphatic Metastasis
18
2024
351
1.250
 Why?
Cell Proliferation
16
2023
2475
1.230
 Why?
Genes, erbB-2
8
2013
28
1.090
 Why?
Cell Cycle
5
2023
601
1.080
 Why?
Mammary Neoplasms, Experimental
6
2017
68
1.040
 Why?
Lymph Node Excision
5
2024
170
0.960
 Why?
MicroRNAs
6
2024
692
0.930
 Why?
Estrogen Receptor alpha
3
2023
145
0.890
 Why?
Apoptosis
21
2018
2551
0.880
 Why?
Cell Line, Tumor
23
2023
3405
0.800
 Why?
Estrogens
2
2023
367
0.790
 Why?
ErbB Receptors
6
2010
613
0.670
 Why?
Up-Regulation
3
2020
844
0.660
 Why?
Hormone Replacement Therapy
1
2020
96
0.640
 Why?
Immunohistochemistry
26
2020
1733
0.610
 Why?
Mammary Neoplasms, Animal
3
2018
33
0.600
 Why?
Triple Negative Breast Neoplasms
3
2016
202
0.590
 Why?
Disease-Free Survival
11
2020
685
0.580
 Why?
Caspases
5
2009
247
0.570
 Why?
Tumor Suppressor Protein p53
14
2011
528
0.540
 Why?
Prognosis
21
2020
4013
0.500
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1396
0.500
 Why?
Antineoplastic Agents
10
2018
2122
0.500
 Why?
Claudins
1
2016
25
0.490
 Why?
Drug Resistance, Neoplasm
10
2023
800
0.480
 Why?
Receptor, IGF Type 1
3
2016
65
0.470
 Why?
Trastuzumab
8
2016
95
0.460
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1682
0.450
 Why?
Transcriptome
1
2020
969
0.440
 Why?
Carcinogenesis
1
2016
217
0.430
 Why?
Carcinoma, Ductal, Breast
5
2002
83
0.430
 Why?
Signal Transduction
16
2023
5076
0.430
 Why?
Seminoma
2
2024
20
0.420
 Why?
Estradiol
2
2009
518
0.410
 Why?
Hypoglycemic Agents
3
2017
1283
0.400
 Why?
Genistein
2
2010
13
0.400
 Why?
Receptors, Steroid
2
2012
50
0.390
 Why?
Doxorubicin
10
2011
362
0.380
 Why?
Female
68
2023
72795
0.380
 Why?
Humans
93
2024
136765
0.370
 Why?
Antineoplastic Agents, Hormonal
5
2020
161
0.370
 Why?
Antimetabolites, Antineoplastic
1
2012
94
0.360
 Why?
Receptors, Progesterone
6
2020
349
0.340
 Why?
Teratoma
2
2022
114
0.330
 Why?
STAT3 Transcription Factor
1
2012
206
0.330
 Why?
Neoplasm Staging
9
2024
1371
0.330
 Why?
Neoplasm Invasiveness
7
2016
507
0.330
 Why?
Genes, p53
5
2000
72
0.320
 Why?
Mice
18
2023
17757
0.320
 Why?
Neoplasm Proteins
5
2016
434
0.300
 Why?
Glucose
1
2013
1019
0.290
 Why?
Glycoproteins
2
2005
342
0.280
 Why?
Retroperitoneal Space
2
2024
20
0.280
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
455
0.280
 Why?
Mammary Tumor Virus, Mouse
2
2004
44
0.270
 Why?
Mice, Transgenic
8
2018
2163
0.270
 Why?
MCF-7 Cells
4
2020
124
0.260
 Why?
Animals
23
2023
36847
0.260
 Why?
Neoplasm, Residual
2
2024
133
0.250
 Why?
Carcinoma
4
1995
238
0.250
 Why?
Antibodies, Monoclonal
7
2013
1430
0.250
 Why?
Bromodeoxyuridine
2
1999
80
0.240
 Why?
Predictive Value of Tests
6
2024
2022
0.240
 Why?
Protein Kinase Inhibitors
3
2016
916
0.240
 Why?
Multivariate Analysis
8
2005
1507
0.230
 Why?
Polymerase Chain Reaction
6
2021
1059
0.230
 Why?
Middle Aged
31
2024
33228
0.230
 Why?
Radiation Tolerance
1
2005
96
0.220
 Why?
Tyrosine
2
2007
222
0.220
 Why?
Enzyme Activation
4
2009
810
0.220
 Why?
Xenograft Model Antitumor Assays
3
2020
868
0.220
 Why?
Quinazolines
2
2016
250
0.220
 Why?
Cocarcinogenesis
1
2003
14
0.210
 Why?
Phosphorylation
5
2011
1758
0.210
 Why?
Survival Analysis
8
2005
1321
0.210
 Why?
Isoflavones
1
2003
26
0.210
 Why?
Cell Survival
5
2018
1116
0.210
 Why?
Paclitaxel
4
2015
227
0.200
 Why?
Chromosomes
1
2003
107
0.200
 Why?
Ki-67 Antigen
4
2014
111
0.190
 Why?
Chromosomes, Human, Pair 8
1
2002
36
0.190
 Why?
Cyclins
2
2000
91
0.190
 Why?
Gelsolin
1
2001
9
0.180
 Why?
Chromosome Aberrations
1
2002
155
0.180
 Why?
Orchiectomy
1
2021
71
0.180
 Why?
Cyclophosphamide
7
2011
247
0.180
 Why?
Retroperitoneal Neoplasms
1
2021
25
0.180
 Why?
Proto-Oncogene Proteins c-ets
2
2020
56
0.180
 Why?
Breast
4
2018
149
0.180
 Why?
Caspase 3
4
2006
246
0.170
 Why?
Rats
7
2022
5639
0.170
 Why?
DNA-Binding Proteins
3
2020
1501
0.170
 Why?
Diet
3
2018
1274
0.170
 Why?
Etoposide
1
2001
158
0.170
 Why?
Obesity
4
2022
2982
0.170
 Why?
Cell Division
6
2005
796
0.170
 Why?
Neoplastic Stem Cells
2
2014
399
0.160
 Why?
Phosphatidylinositol 3-Kinases
3
2011
366
0.160
 Why?
Mice, SCID
1
2020
366
0.160
 Why?
TOR Serine-Threonine Kinases
3
2012
412
0.160
 Why?
Transcription Factors
3
2020
1718
0.160
 Why?
Drug Screening Assays, Antitumor
3
2016
194
0.160
 Why?
Prospective Studies
4
2024
7572
0.160
 Why?
Proto-Oncogene Proteins
5
2008
647
0.160
 Why?
Carcinoma, Papillary
1
1999
81
0.160
 Why?
Mitotic Index
1
1999
25
0.150
 Why?
Mice, Inbred NOD
1
2020
600
0.150
 Why?
Receptors, Androgen
2
2017
150
0.150
 Why?
Chemotherapy, Adjuvant
5
2015
387
0.150
 Why?
Adult
20
2024
37631
0.150
 Why?
Ovarian Neoplasms
4
1995
562
0.150
 Why?
Aromatase
1
2018
32
0.150
 Why?
Kaplan-Meier Estimate
1
2020
888
0.140
 Why?
Drug Synergism
3
2018
382
0.140
 Why?
Tumor Cells, Cultured
6
2009
953
0.140
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
53
0.140
 Why?
HSP90 Heat-Shock Proteins
1
2018
46
0.140
 Why?
Phenylthiohydantoin
2
2017
42
0.140
 Why?
Antigens, Neoplasm
2
2009
319
0.140
 Why?
Autism Spectrum Disorder
1
2023
395
0.140
 Why?
Down-Regulation
3
2010
656
0.140
 Why?
In Situ Hybridization, Fluorescence
4
2008
317
0.140
 Why?
Ovariectomy
4
2022
152
0.140
 Why?
Fluorouracil
5
2009
208
0.140
 Why?
Tumor Burden
4
2022
309
0.130
 Why?
Poly(ADP-ribose) Polymerases
2
2009
98
0.130
 Why?
Antibodies, Monoclonal, Humanized
5
2013
801
0.130
 Why?
Postmenopause
5
2022
365
0.130
 Why?
Organic Cation Transport Proteins
1
2017
26
0.130
 Why?
Triazoles
1
2018
147
0.130
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
234
0.120
 Why?
Smad Proteins
1
2016
42
0.120
 Why?
Cathepsin D
2
2002
18
0.120
 Why?
Gene Knock-In Techniques
1
2016
56
0.120
 Why?
Calcitriol
1
2016
58
0.120
 Why?
Antibiotics, Antineoplastic
3
2009
127
0.120
 Why?
Ovary
1
2017
221
0.120
 Why?
Proteins
2
1992
1008
0.120
 Why?
Gene Amplification
2
2009
104
0.120
 Why?
Protein Tyrosine Phosphatases
1
2016
172
0.110
 Why?
Fatty Acid Synthase, Type I
1
2014
11
0.110
 Why?
Immunoradiometric Assay
1
1994
2
0.110
 Why?
Mental Disorders
1
2023
1070
0.110
 Why?
Immunoprecipitation
2
2011
155
0.110
 Why?
Young Adult
4
2024
13127
0.110
 Why?
Androgen Receptor Antagonists
1
2014
34
0.110
 Why?
Postpartum Period
2
2014
337
0.110
 Why?
Disease Progression
6
2018
2750
0.110
 Why?
Insulin-Like Growth Factor I
1
2016
316
0.100
 Why?
Mice, Knockout
1
2020
3008
0.100
 Why?
Androgen Antagonists
1
2014
82
0.100
 Why?
Receptor, ErbB-4
2
2010
19
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
75
0.100
 Why?
Transforming Growth Factor beta
1
2016
480
0.100
 Why?
Adenocarcinoma
3
2012
938
0.100
 Why?
Blotting, Western
3
2011
1225
0.100
 Why?
Overnutrition
1
2012
30
0.100
 Why?
Vitamin D
1
2016
397
0.100
 Why?
Sweden
2
2024
101
0.100
 Why?
Nucleic Acid Hybridization
2
2003
190
0.100
 Why?
Aminosalicylic Acids
1
2012
5
0.100
 Why?
DNA, Neoplasm
6
2005
164
0.090
 Why?
Benzenesulfonates
1
2012
22
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
233
0.090
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
56
0.090
 Why?
Chromones
1
2011
44
0.090
 Why?
RNA, Messenger
4
2016
2831
0.090
 Why?
Disease Models, Animal
4
2017
4282
0.090
 Why?
Gene Expression Profiling
2
2016
1772
0.090
 Why?
Genital Diseases, Female
1
1991
28
0.090
 Why?
Dasatinib
1
2011
54
0.090
 Why?
Fluoxymesterone
1
1991
2
0.090
 Why?
Proportional Hazards Models
4
2005
1261
0.090
 Why?
Thiazoles
1
2011
123
0.090
 Why?
Apoptosis Regulatory Proteins
1
2012
188
0.090
 Why?
Aged
14
2015
23794
0.090
 Why?
S Phase
2
2010
77
0.090
 Why?
Mitosis
3
2001
192
0.090
 Why?
Morpholines
1
2011
122
0.090
 Why?
Reagent Kits, Diagnostic
1
1991
42
0.090
 Why?
Cohort Studies
2
2020
5701
0.090
 Why?
Weight Gain
3
2022
519
0.080
 Why?
Genital Neoplasms, Female
1
1991
89
0.080
 Why?
Chromosomes, Human, Pair 17
3
2002
55
0.080
 Why?
Proto-Oncogenes
1
1989
29
0.080
 Why?
Neoplasm Metastasis
5
2005
657
0.080
 Why?
Radioisotopes
1
1989
31
0.080
 Why?
Flow Cytometry
3
2007
1180
0.080
 Why?
Dose-Response Relationship, Drug
2
2008
2052
0.080
 Why?
Aged, 80 and over
6
2002
7585
0.080
 Why?
Anthracyclines
1
2009
42
0.080
 Why?
DNA Topoisomerases, Type II
1
2009
45
0.080
 Why?
Follow-Up Studies
5
2020
5106
0.080
 Why?
Male
7
2024
67311
0.070
 Why?
Gene Deletion
2
2002
389
0.070
 Why?
Treatment Outcome
5
2007
10745
0.070
 Why?
Pyrimidines
1
2011
470
0.070
 Why?
RNA, Small Interfering
2
2007
622
0.070
 Why?
MAP Kinase Signaling System
1
2010
320
0.070
 Why?
AMP-Activated Protein Kinases
1
2009
197
0.070
 Why?
Epithelial Cells
1
2014
1094
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
975
0.070
 Why?
Gene Dosage
1
2008
140
0.070
 Why?
Mice, Nude
1
2009
696
0.070
 Why?
Mutation
3
1995
3946
0.070
 Why?
Reproducibility of Results
3
2023
3265
0.070
 Why?
Protein Structure, Tertiary
1
2009
860
0.070
 Why?
Immunoenzyme Techniques
3
1999
219
0.070
 Why?
Time Factors
4
2015
6808
0.070
 Why?
Energy Metabolism
1
2012
919
0.060
 Why?
Proto-Oncogene Proteins c-akt
3
2016
437
0.060
 Why?
Enzyme Precursors
1
2006
15
0.060
 Why?
Aging
4
2003
1864
0.060
 Why?
Cell Nucleus
4
2006
617
0.060
 Why?
Receptor, Notch1
1
2006
64
0.060
 Why?
Multigene Family
2
2003
198
0.060
 Why?
Lamin Type B
1
2005
7
0.060
 Why?
Mitochondria
3
2008
946
0.060
 Why?
Epigenesis, Genetic
1
2010
657
0.060
 Why?
Herpes Simplex
1
2006
95
0.060
 Why?
Survival Rate
4
2020
1963
0.060
 Why?
Herpesvirus 1, Human
1
2006
87
0.060
 Why?
Cell Nucleolus
1
2005
17
0.060
 Why?
Age Factors
3
2003
3284
0.060
 Why?
Nitriles
2
2017
172
0.060
 Why?
Benzamides
2
2017
216
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
121
0.060
 Why?
Feedback
1
2005
172
0.060
 Why?
Antineoplastic Agents, Phytogenic
2
2007
190
0.060
 Why?
RNA Interference
3
2015
466
0.060
 Why?
Tumor Microenvironment
2
2018
672
0.050
 Why?
Protein Kinases
1
2006
319
0.050
 Why?
Tacrolimus Binding Protein 1A
1
2003
10
0.050
 Why?
Tacrolimus Binding Proteins
1
2003
27
0.050
 Why?
Rats, Wistar
2
2017
455
0.050
 Why?
Mice, Inbred Strains
1
2004
409
0.050
 Why?
Estrogens, Non-Steroidal
1
2003
10
0.050
 Why?
Genes, Tumor Suppressor
1
2003
86
0.050
 Why?
Adipose Tissue
2
2018
630
0.050
 Why?
Phytoestrogens
1
2003
17
0.050
 Why?
Estrogen Antagonists
1
2003
45
0.050
 Why?
Plant Preparations
1
2003
36
0.050
 Why?
Cell Line
2
2003
2838
0.050
 Why?
Actins
1
2005
416
0.050
 Why?
Chromosome Banding
1
2002
19
0.050
 Why?
Anticarcinogenic Agents
1
2003
77
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
36
0.050
 Why?
Embryoid Bodies
1
2022
8
0.050
 Why?
Mammary Glands, Animal
1
2003
129
0.050
 Why?
Rodentia
1
2022
57
0.050
 Why?
Transfection
3
2015
941
0.050
 Why?
3' Untranslated Regions
2
2014
145
0.050
 Why?
Trefoil Factor-1
2
1992
2
0.050
 Why?
alpha-Fetoproteins
1
2021
46
0.050
 Why?
Fallopian Tubes
2
1991
31
0.050
 Why?
In Situ Nick-End Labeling
1
2001
124
0.040
 Why?
Chorionic Gonadotropin
1
2021
80
0.040
 Why?
Nuclear Proteins
2
2000
712
0.040
 Why?
RNA, Catalytic
1
2002
187
0.040
 Why?
DNA Fragmentation
1
2001
41
0.040
 Why?
Plasmids
1
2002
360
0.040
 Why?
Inhibitory Concentration 50
1
2001
90
0.040
 Why?
Antigens, Nuclear
1
2000
18
0.040
 Why?
Fibrosis
1
2023
551
0.040
 Why?
RNA Stability
1
2021
117
0.040
 Why?
Breast Diseases
1
2000
22
0.040
 Why?
Enhancer Elements, Genetic
1
2000
190
0.040
 Why?
Integrin beta3
2
2013
11
0.040
 Why?
Tumor Suppressor Proteins
2
1992
327
0.040
 Why?
Telomerase
1
2001
250
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
6
0.040
 Why?
Methylnitrosourea
1
2018
7
0.040
 Why?
DNA Glycosylases
1
1998
8
0.040
 Why?
Antibodies
1
2000
411
0.040
 Why?
Loss of Function Mutation
1
2018
46
0.040
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
44
0.040
 Why?
Trans-Activators
1
2000
398
0.040
 Why?
Codon
3
1993
89
0.040
 Why?
Half-Life
1
2018
164
0.040
 Why?
NF-kappa B
1
2002
691
0.040
 Why?
Stromal Cells
1
2018
112
0.040
 Why?
Case-Control Studies
2
2023
3539
0.040
 Why?
Hyaluronan Receptors
1
1998
103
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
182
0.030
 Why?
Gene Expression
3
2013
1500
0.030
 Why?
Organic Cation Transporter 2
1
2017
8
0.030
 Why?
Retrospective Studies
4
2005
15504
0.030
 Why?
Cell Movement
1
2001
968
0.030
 Why?
Extracellular Matrix Proteins
1
1998
153
0.030
 Why?
Steroids
1
2017
167
0.030
 Why?
DNA Repair
1
1998
231
0.030
 Why?
Antigens, CD
2
2014
521
0.030
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
11
0.030
 Why?
Oncogenes
1
2016
116
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
26
0.030
 Why?
Chromatography, Liquid
1
2017
433
0.030
 Why?
Oncogene Proteins
1
1995
59
0.030
 Why?
Analysis of Variance
2
2014
1316
0.030
 Why?
RNA
1
2001
921
0.030
 Why?
Homeodomain Proteins
1
2018
506
0.030
 Why?
Tosyl Compounds
1
2014
15
0.030
 Why?
Adolescent
3
2024
21382
0.030
 Why?
Mammary Glands, Human
1
2014
64
0.030
 Why?
Integrin alpha6
1
2013
9
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
283
0.030
 Why?
Leukocyte Common Antigens
1
2014
87
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
61
0.030
 Why?
Mass Spectrometry
1
2017
738
0.030
 Why?
Parity
1
2014
125
0.030
 Why?
Tomography, X-Ray Computed
1
2024
2667
0.030
 Why?
Testosterone
1
2017
401
0.030
 Why?
Anilides
1
2014
73
0.030
 Why?
Premenopause
1
2014
131
0.030
 Why?
Immunoassay
1
1994
113
0.030
 Why?
Transplantation, Heterologous
1
2014
194
0.030
 Why?
Neovascularization, Pathologic
1
1995
301
0.030
 Why?
Neoplasm Transplantation
1
2014
257
0.030
 Why?
bcl-2-Associated X Protein
2
2007
56
0.030
 Why?
Sirolimus
2
2006
275
0.030
 Why?
Organ Specificity
1
2013
304
0.030
 Why?
Interleukin-6
1
2017
778
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2013
49
0.020
 Why?
Lactation
1
2014
181
0.020
 Why?
Immune System
1
2014
177
0.020
 Why?
Neoplasms
2
2012
2643
0.020
 Why?
Brain Neoplasms
2
1993
1235
0.020
 Why?
Lipogenesis
1
2012
61
0.020
 Why?
Point Mutation
1
1993
235
0.020
 Why?
Molecular Targeted Therapy
1
2015
411
0.020
 Why?
Broad Ligament
1
1991
1
0.020
 Why?
Astrocytoma
1
1993
128
0.020
 Why?
Gene Knockdown Techniques
1
2013
327
0.020
 Why?
Tumor Necrosis Factor-alpha
2
2007
1242
0.020
 Why?
Peritoneum
1
1991
43
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
51
0.020
 Why?
Mucins
1
1991
73
0.020
 Why?
Glycolysis
1
2012
319
0.020
 Why?
Blotting, Northern
1
2010
200
0.020
 Why?
Evaluation Studies as Topic
1
1991
180
0.020
 Why?
Hormones
1
1991
142
0.020
 Why?
In Situ Hybridization
1
2010
316
0.020
 Why?
Pilot Projects
1
2015
1692
0.020
 Why?
Soft Tissue Neoplasms
1
1991
115
0.020
 Why?
Cells, Cultured
2
2013
4191
0.020
 Why?
Precipitin Tests
1
1989
100
0.020
 Why?
Pregnancy
2
2014
6726
0.020
 Why?
Radionuclide Imaging
1
1989
118
0.020
 Why?
Odds Ratio
1
1992
1065
0.020
 Why?
Glioblastoma
1
1993
343
0.020
 Why?
Risk Factors
1
2003
10325
0.020
 Why?
Protein Multimerization
1
2010
191
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
766
0.020
 Why?
Lymph Nodes
1
1991
492
0.020
 Why?
Drug Interactions
1
2009
407
0.020
 Why?
Cytochromes c
1
2007
60
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
71
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Caspase 2
1
2006
13
0.020
 Why?
Caspase 8
1
2006
48
0.020
 Why?
Caspase 9
1
2006
57
0.020
 Why?
Amino Acid Sequence
3
1998
2138
0.020
 Why?
Cysteine Endopeptidases
1
2006
72
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
14
0.020
 Why?
Caspase 7
1
2006
22
0.020
 Why?
Eukaryotic Initiation Factor-4E
1
2006
27
0.020
 Why?
Isoenzymes
1
2007
304
0.020
 Why?
Vero Cells
1
2006
68
0.020
 Why?
Cytosol
1
2006
226
0.020
 Why?
Biomarkers
1
2017
4144
0.020
 Why?
Base Sequence
2
2003
2179
0.020
 Why?
Promoter Regions, Genetic
1
2010
1249
0.020
 Why?
Virus Assembly
1
2006
77
0.010
 Why?
Taxoids
1
2004
102
0.010
 Why?
Protein Binding
1
2010
2216
0.010
 Why?
Protein Processing, Post-Translational
1
2006
465
0.010
 Why?
DNA, Complementary
1
2003
271
0.010
 Why?
Melanoma, Experimental
1
2003
114
0.010
 Why?
Americas
1
2002
28
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2002
29
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
79
0.010
 Why?
Endothelial Growth Factors
1
2002
64
0.010
 Why?
Lymphokines
1
2002
131
0.010
 Why?
Plasminogen Activator Inhibitor 1
1
2002
86
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
36
0.010
 Why?
Cell Adhesion
1
2003
466
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
52
0.010
 Why?
Mice, Inbred C57BL
2
2003
5749
0.010
 Why?
Gene Targeting
1
2002
81
0.010
 Why?
Exons
2
1993
351
0.010
 Why?
Europe
1
2002
413
0.010
 Why?
Templates, Genetic
1
2001
63
0.010
 Why?
Substrate Specificity
1
2002
371
0.010
 Why?
Molecular Sequence Data
2
1998
2894
0.010
 Why?
DNA, Superhelical
1
2000
11
0.010
 Why?
DNA Footprinting
1
2000
33
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2002
382
0.010
 Why?
Mice, Inbred BALB C
1
2003
1269
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Data Interpretation, Statistical
1
2002
363
0.010
 Why?
Ploidies
1
2000
18
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
113
0.010
 Why?
Macromolecular Substances
1
2000
229
0.010
 Why?
Pathology, Clinical
1
2000
36
0.010
 Why?
Gene Silencing
1
2000
195
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2002
543
0.010
 Why?
Multicenter Studies as Topic
1
2000
308
0.010
 Why?
Forecasting
1
2000
386
0.010
 Why?
Genetic Therapy
1
2000
293
0.010
 Why?
Receptors, Cell Surface
1
2000
382
0.010
 Why?
Binding Sites
1
2000
1301
0.010
 Why?
Nucleic Acid Conformation
1
2000
728
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
15
0.010
 Why?
ras Proteins
1
1998
153
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
50
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
59
0.010
 Why?
Immunoblotting
1
1997
306
0.010
 Why?
Adenine
1
1998
270
0.010
 Why?
Societies, Medical
1
2000
816
0.010
 Why?
Heterozygote
1
1996
293
0.010
 Why?
Hyaluronic Acid
1
1998
222
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
26
0.010
 Why?
Protein Isoforms
1
1997
403
0.010
 Why?
Cyclin D1
1
1995
68
0.010
 Why?
Melanoma
1
2002
757
0.010
 Why?
United States
2
2004
14690
0.010
 Why?
Factor VIII
1
1995
98
0.010
 Why?
Single-Blind Method
1
1995
282
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1462
0.010
 Why?
Observer Variation
1
1995
341
0.010
 Why?
Transcription, Genetic
1
2000
1455
0.010
 Why?
Alleles
1
1996
890
0.010
 Why?
Biopsy
1
1995
1124
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
53
0.010
 Why?
Peripheral Nerves
1
1991
65
0.010
 Why?
Risk Assessment
1
2000
3432
0.010
 Why?
DNA
1
1996
1458
0.010
 Why?
Polymorphism, Genetic
1
1993
659
0.000
 Why?
Protein Conformation
1
1993
933
0.000
 Why?
Lung Neoplasms
1
2002
2489
0.000
 Why?
Cerebral Cortex
1
1991
433
0.000
 Why?
Glioma
1
1991
395
0.000
 Why?
Child
1
1993
21819
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (453) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)